Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
02/19/2004 | WO2004014377A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
02/19/2004 | WO2004014372A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
02/19/2004 | WO2004014369A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
02/19/2004 | WO2004014366A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
02/19/2004 | WO2004014365A1 Phthalimide derivatives as matrix metalloproteinase inhibitors |
02/19/2004 | WO2004014300A2 Tyrosine kinase inhibitors |
02/19/2004 | WO2004007481A3 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
02/19/2004 | WO2003086306A3 5ht2c receptor modulators |
02/19/2004 | WO2003057213A3 Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
02/19/2004 | WO2003027234A9 Small organic molecule regulators of cell proliferation |
02/19/2004 | US20040034230 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent |
02/19/2004 | US20040034229 3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists |
02/19/2004 | US20040034222 Phenyloxyalkylamino substituted triazine compound, useful for applying to the parts of the plants, to plant seed or to the area under cultivation as plant growth regulator |
02/19/2004 | US20040034219 Benzothiophene derivative compounds process of preparation and use thereof |
02/19/2004 | US20040034081 Estrogen receptor modulators |
02/19/2004 | US20040034078 Such as 2-(2-butylamino-ethylsulfanylmethyl)-1H-benzimidazole-4-carboxylic acid amide for treatment of cancer, strokes, head trauma, and neurodengenerative diseases; solid phase synthesis |
02/19/2004 | US20040034049 A benzofuran derivatives for treating neurodegenerative disease, such as Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis and Huntington's disease |
02/19/2004 | US20040034047 E.g. 5-(6,7-dimethoxy-2-(4-methoxybenzyl)benzofuran-4-yl-methyl-)pyrimidine-2,4 -diamine; bactericides for infections of grampositive and gramnegative pathogens; more potent than Trimethoprim, especially against respiratory tract pathogens |
02/19/2004 | US20040034037 Heteroaryl compounds useful as inhibitors of GSK-3 |
02/19/2004 | US20040034034 Novel piperazine derivatives |
02/19/2004 | US20040034031 3,4-Disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines |
02/19/2004 | US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
02/19/2004 | US20040034019 Piperazine and piperidine derivatives |
02/19/2004 | US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
02/19/2004 | US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings |
02/19/2004 | DE10236340A1 New heteroar(alkan)oyl-substituted phenyl-beta-alaninamide derivatives, useful as broad-spectrum antibacterial agents in human or veterinary medicine |
02/19/2004 | DE10235690A1 New N-benzyl-anthranilic acid (hetero)arylamide derivatives and analogs, are tyrosine kinase KDR and FLT inhibitors and angiogenesis inhibitors, useful e.g. for treating tumors, psoriasis or restenosis |
02/19/2004 | CA2495285A1 Phenylpyridazine derivatives as ligands for gaba receptors |
02/19/2004 | CA2494942A1 Substituted benzimidazole compounds |
02/19/2004 | CA2494298A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
02/19/2004 | CA2494048A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
02/19/2004 | CA2493908A1 Thiophene compounds |
02/19/2004 | CA2493575A1 Tyrosine kinase inhibitors |
02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
02/18/2004 | EP1389460A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound |
02/18/2004 | EP1389206A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
02/18/2004 | EP1389202A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
02/18/2004 | EP1389110A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
02/18/2004 | EP1244655B1 Antithrombotic agents |
02/18/2004 | EP1216238B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
02/18/2004 | EP1196410B1 Respiratory syncytial virus replication inhibitors |
02/18/2004 | EP1183252B1 pharmaceutically active compounds |
02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
02/18/2004 | EP1049691B1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
02/18/2004 | CN1476446A Benzodiazepine derivative |
02/18/2004 | CN1476442A Pyridine derivatives with IKB-kinase (IKK-beta) INhibiting activity |
02/18/2004 | CN1476436A Novel compounds for use as HIV protease inhibitors |
02/18/2004 | CN1476430A Delta 1-pyrrolines used as pesticides |
02/18/2004 | CN1476429A EP4 receptor selective agonists in treatment of osteoporosis |
02/18/2004 | CN1138773C 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2 |
02/18/2004 | CN1138771C 6-hydroxy-3-(4-[2-piperidine-1-group) oxyethyl group] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride salt |
02/18/2004 | CN1138770C 6-carbonyl-3-(4-[2-pierid-1-yl)elhoyl]phenoxy)-2-(4-methoxylphenyl) benzo[b] thiophene salt crystal |
02/18/2004 | CN1138761C 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and use as dopamine autoreceptor (D2) agonists |
02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
02/17/2004 | US6693200 2-(substituted-phenyl)amino-imidazoline derivatives |
02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
02/17/2004 | US6693121 As inhibitors of serine proteases of the coagulation cascade and compounds, used for anticoagulant therapy forprophylaxis of a variety of thrombotic conditions including coronary artery and cerebrovascular diseases |
02/17/2004 | US6693117 Compounds with analgesic effect |
02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
02/17/2004 | US6692657 Alkenyl compound with 2,3-difluorophenyl group |
02/17/2004 | CA2302965C Processes and intermediates for preparing anti-cancer compounds |
02/12/2004 | WO2004013131A2 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl |
02/12/2004 | WO2004013130A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
02/12/2004 | WO2004013122A2 Octupolar molecules used as organic semi-conductors |
02/12/2004 | WO2004013102A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
02/12/2004 | WO2004013093A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
02/12/2004 | WO2004012736A1 Biaryl compounds having anti-infective activity |
02/12/2004 | WO2004012648A2 Substituted diaryl heterocycles, method for the production and use thereof as medicaments |
02/12/2004 | WO2003103604A3 Gamma lactams as prostaglandin agonists and use thereof |
02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
02/12/2004 | WO2003037916A3 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
02/12/2004 | WO2002042289A8 Process for preparing 3-aryl-benzo[b]thiophenes |
02/12/2004 | US20040030181 Process for stereoselectively reducing 4-aryl-4-oxobutanoic acid derivatives |
02/12/2004 | US20040030156 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
02/12/2004 | US20040030137 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
02/12/2004 | US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
02/12/2004 | US20040029920 2-(biarylalkyl)amino-3-(heterocyclylcarbonylamino)-pyridine derivatives |
02/12/2004 | US20040029919 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
02/12/2004 | US20040029902 2,4-Pyrimidinediamine compounds and their uses |
02/12/2004 | US20040029898 Anticancer agents |
02/12/2004 | US20040029887 Cardiovascular disorders; antiinflammatory agents; central nervous system diosrders; psychological disorders |
02/12/2004 | US20040029883 Beta-amino acid compounds as integrin antagonists |
02/12/2004 | US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
02/12/2004 | US20040029874 Anticoagulants; cardiovascular disorders |
02/12/2004 | US20040029867 Anticoagulants; cardiovascular disorders |
02/12/2004 | US20040029863 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
02/12/2004 | US20040029862 Alzheimer's disease |
02/12/2004 | US20040029861 Using compound containing pyridine ring |
02/12/2004 | US20040028582 Using solvent, nonsolvent precipitation of drugs |
02/12/2004 | US20040026663 Transition metal complexes |
02/12/2004 | DE10234188A1 Oktupolare Moleküle als organische Halbleiter Octupolar molecules as organic semiconductors |
02/12/2004 | DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments |
02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
02/12/2004 | CA2494593A1 4-trifluormethylpyrazolyl-substituted pyridines and pyrimidines |
02/12/2004 | CA2494139A1 Biaryl compounds having anti-infective activity |
02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
02/12/2004 | CA2494074A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |